🟢 Pyxis Oncology is trading 5.4% up in after-hours trading — catalyst unclear

Pyxis Oncology is trading 5.38% up in after-hours at $2.13, with no new company-specific announcement identified to explain the rise.

• The October 6 regular-session close was $2.02, following a 9.82% decline.
• The latest listed company release was its October 2 public-offering update.
• Biotechnology stocks were weak; XBI was reported down 3.45% in afternoon trading, a backdrop that does not explain the opposite-direction after-hours move.